Chiara Chiozzini

9PUBLICATIONS
13CO-AUTHORS
Animal protection (incl. pests and pathogens)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Towards an Original Anti-ASFV Vaccine: Cellular Immunity Induced by Extracellular Vesicles Engineered with ASFV Proteins.

|Sep 19, 2024
Extracellular vesicle-based anti-HOXB7 CD8+ T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neu.

Flavia Ferrantelli, Francesco Manfredi, Micaela Donnini

|Sep 28, 2023
SARS-CoV-2-Specific CD8+ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection.

Flavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini

|Jul 27, 2022
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein.

Francesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli

|Feb 26, 2022
Strong SARS-CoV-2 N-Specific CD8+ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice.

Flavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi

|Jun 02, 2021
Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles.

Flavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini

Pageof 2

Frequent Collaborators

8 joint publications

Flavia Ferrantelli

7 joint publications

Francesco Manfredi

7 joint publications

Maurizio Federico

2 joint publications

Massimo Sanchez